Clinical Trial of Safety and Immunogenicity of Recombinant SARS-CoV-2 S-Trimer Vaccine (CHO Cells) as Booster Vaccination in Populations Aged 18 to 59 Years
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Related studies linked through entity extraction aliases.